{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,13]],"date-time":"2025-04-13T04:58:27Z","timestamp":1744520307866},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T00:00:00Z","timestamp":1625443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T00:00:00Z","timestamp":1625443200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s00105-021-04850-0","type":"journal-article","created":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T08:10:51Z","timestamp":1625472651000},"page":"706-714","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Hidradenitis suppurativa\/Acne inversa in der Praxis","Hidradenitis suppurativa\/acne inversa in daily practice"],"prefix":"10.1007","volume":"72","author":[{"given":"H.","family":"Kurzen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Fritz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Altenburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,7,5]]},"reference":[{"issue":"4","key":"4850_CR1","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1111\/bjd.17422","volume":"180","author":"J Albrecht","year":"2019","unstructured":"Albrecht\u00a0J, Barbaric\u00a0J, Nast\u00a0A (2019) Rifampicin alone may be enough: is it time to abandon the classic oral clindamycin-rifampicin combination for hidradenitis suppurativa? Br J Dermatol 180(4):949\u2013950","journal-title":"Br J Dermatol"},{"issue":"2","key":"4850_CR2","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/ijd.14691","volume":"59","author":"F Choi","year":"2020","unstructured":"Choi\u00a0F, Lehmer\u00a0L, Ekelem\u00a0C, Mesinkovska\u00a0NA (2020) Dietary and metabolic factors in the pathogenesis of hidradenitis suppurativa: a\u00a0systematic review. Int J Dermatol 59(2):143\u2013153","journal-title":"Int J Dermatol"},{"issue":"5","key":"4850_CR3","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1024\/0040-5930\/a001176","volume":"77","author":"S Eichenberger","year":"2020","unstructured":"Eichenberger\u00a0S (2020) Versorgung von Hautabszessen auf der Notfallstation [Treatment of Skin Abscesses in the Emergency Department]. Ther Umsch 77(5):207\u2013212","journal-title":"Ther Umsch"},{"issue":"3","key":"4850_CR4","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1684\/ejd.2019.3552","volume":"29","author":"VG Frings","year":"2019","unstructured":"Frings\u00a0VG, Bauer\u00a0B, Gl\u00f6ditzsch\u00a0M, Goebeler\u00a0M, Presser\u00a0D (2019) Assessing the psychological burden of patients with hidradenitis suppurativa. Eur J Dermatol 29(3):294\u2013301","journal-title":"Eur J Dermatol"},{"issue":"5 Suppl 1","key":"4850_CR5","doi-asserted-by":"publisher","first-page":"S78","DOI":"10.1016\/j.jaad.2015.07.050","volume":"73","author":"IH Hamzavi","year":"2015","unstructured":"Hamzavi\u00a0IH, Griffith\u00a0JL, Riyaz\u00a0F, Hessam\u00a0S, Bechara\u00a0FG (2015) Laser and light-based treatment options for hidradenitis suppurativa. J\u00a0Am Acad Dermatol 73(5 Suppl 1):S78\u2013S81","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"4850_CR6","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1097\/PRS.0b013e31821e6fb5","volume":"128","author":"L Highton","year":"2011","unstructured":"Highton\u00a0L, Chan\u00a0WY, Khwaja\u00a0N, Laitung\u00a0JK (2011) Treatment of hidradenitis suppurativa with intense pulsed light: a\u00a0prospective study. Plast Reconstr Surg 128(2):459\u2013465","journal-title":"Plast Reconstr Surg"},{"issue":"1","key":"4850_CR7","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1097\/00042728-200801000-00025","volume":"34","author":"J Iwasaki","year":"2008","unstructured":"Iwasaki\u00a0J, Marra\u00a0DE, Fincher\u00a0EF et\u00a0al (2008) Treatment of hidradenitis suppurativa with a\u00a0nonablative radiofrequency device. Dermatol Surg 34(1):114\u2013117","journal-title":"Dermatol Surg"},{"issue":"1","key":"4850_CR8","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1684\/ejd.2013.2213","volume":"24","author":"O Join-Lambert","year":"2014","unstructured":"Join-Lambert\u00a0O, Ribadeau-Dumas\u00a0F, Jullien\u00a0V et al (2014) Dramatic reduction of clindamycin plasma concentration in hidradenitis suppurativa patients treated with the rifampin-clindamycin combination. Eur J Dermatol 24(1):94\u201395","journal-title":"Eur J Dermatol"},{"key":"4850_CR9","volume-title":"Comprehensive study of hidradenitis suppurativa in the perspective of pathogenesis and clinical and histological therapeutic efficacy of fractional microneedling radiofrequency","author":"DH Kim","year":"2021","unstructured":"Kim\u00a0DH, Yang\u00a0JH, Cho\u00a0SI et al (2021) Comprehensive study of hidradenitis suppurativa in the perspective of pathogenesis and clinical and histological therapeutic efficacy of fractional microneedling radiofrequency. E\u2011poster, EHSF."},{"issue":"5","key":"4850_CR10","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1056\/NEJMoa1504370","volume":"375","author":"AB Kimball","year":"2016","unstructured":"Kimball\u00a0AB, Okun\u00a0MM, Williams\u00a0DA et\u00a0al (2016) Two phase 3 trials of adalimumab for hidradenitis suppurativa. N\u00a0Engl J Med 375(5):422\u2013434","journal-title":"N Engl J Med"},{"issue":"3","key":"4850_CR11","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1159\/000018126","volume":"198","author":"A K\u00f6nig","year":"1999","unstructured":"K\u00f6nig\u00a0A, Lehmann\u00a0C, Rompel\u00a0R, Happle\u00a0R (1999) Cigarette smoking as a\u00a0triggering factor of hidradenitis suppurativa. Dermatology 198(3):261\u2013264","journal-title":"Dermatology"},{"key":"4850_CR12","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/j.1600-0625.2008.00712_1.x","volume":"17","author":"H Kurzen","year":"2008","unstructured":"Kurzen\u00a0H, Kurokawa\u00a0I, Jemec\u00a0GBE et\u00a0al (2008) What causes hidradenitis suppurativa? Exp Dermatol 17:455\u2013472","journal-title":"Exp Dermatol"},{"key":"4850_CR13","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/exd.13232","volume":"26","author":"H Kurzen","year":"2017","unstructured":"Kurzen\u00a0H (2017) Usefulness of a\u00a0fix combination cream of fusidic acid and betamethasone in the treatment of hidradenitis suppurativa. Exp Dermatol 26:24","journal-title":"Exp Dermatol"},{"issue":"2","key":"4850_CR14","doi-asserted-by":"publisher","first-page":"8243","DOI":"10.4081\/dr.2019.8243","volume":"11","author":"H Kurzen","year":"2019","unstructured":"Kurzen\u00a0H, Kurzen\u00a0M (2019) Secondary prevention of hidradenitis suppurativa. Dermatol Reports 11(2):8243","journal-title":"Dermatol Reports"},{"issue":"11","key":"4850_CR15","first-page":"23","volume":"68","author":"H Kurzen","year":"2020","unstructured":"Kurzen\u00a0H, Kiedrowski\u00a0R, Quist\u00a0S, Sebastian\u00a0M, Termeer\u00a0C (2020) Atopische Dermatitis: Ein praxisnaher Behandlungspfad. Dtsch Dermatolog 68(11):23","journal-title":"Dtsch Dermatolog"},{"issue":"2","key":"4850_CR16","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1097\/DSS.0000000000000264","volume":"41","author":"PR Mikkelsen","year":"2015","unstructured":"Mikkelsen\u00a0PR, Dufour\u00a0DN, Zarchi\u00a0K, Jemec\u00a0GB (2015) Recurrence rate and patient satisfaction of CO2 laser evaporation of lesions in patients with hidradenitis suppurativa: a\u00a0retrospective study. Dermatol Surg 41(2):255\u2013260","journal-title":"Dermatol Surg"},{"issue":"1","key":"4850_CR17","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.1111\/bjd.15735","volume":"178","author":"P Perng","year":"2018","unstructured":"Perng\u00a0P, Zampella\u00a0JG, Okoye\u00a0GA (2018) Considering the impact of pregnancy on the natural history of hidradenitis suppurativa. Br J Dermatol 178(1):e13\u2013e14","journal-title":"Br J Dermatol"},{"issue":"5","key":"4850_CR18","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s40257-018-0374-5","volume":"19","author":"I Poveda","year":"2018","unstructured":"Poveda\u00a0I, Vilarrasa\u00a0E, Martorell\u00a0A et al (2018) Serum zinc levels in hidradenitis suppurativa: a case-control study. Am J Clin Dermatol 19(5):771\u2013777","journal-title":"Am J Clin Dermatol"},{"key":"4850_CR19","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1007\/s00105-017-4082-5","volume":"68","author":"R Sabat","year":"2017","unstructured":"Sabat\u00a0R, Tsaousi\u00a0A, Rossbacher\u00a0J et\u00a0al (2017) Acne inversa \/ Hidradenitis suppurativa: ein update. Hautarzt 68:999\u20131006","journal-title":"Hautarzt"},{"key":"4850_CR20","volume-title":"LAight\u00aetherapy is an effective treatment option in patients with hidradenitis suppurativa Hurley stage I and II: a\u00a0multicenter randomized, controlled trial (RELIEVE)","author":"M Schultheis","year":"2021","unstructured":"Schultheis\u00a0M, Staubach\u00a0P, Nikolakis\u00a0G et al (2021) LAight\u00aetherapy is an effective treatment option in patients with hidradenitis suppurativa Hurley stage I and II: a\u00a0multicenter randomized, controlled trial (RELIEVE). E\u2011poster, EHSF."},{"key":"4850_CR21","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1111\/j.1524-4725.2009.01214.x","volume":"35","author":"E Tierney","year":"2009","unstructured":"Tierney\u00a0E, Mahmoud\u00a0BH, Hexsel\u00a0C, Ozog\u00a0D, Hamzavi\u00a0I (2009) Randomized control trial for the treatment of hidradenitis suppurativa with a\u00a0neodymium-doped Yttrium Aluminium Garnet Laser. Dermatol Surg 35:1188\u20131198","journal-title":"Dermatol Surg"},{"key":"4850_CR22","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jaad.2016.07.024","volume":"76","author":"AR Vossen","year":"2017","unstructured":"Vossen\u00a0AR, van Straalen\u00a0KR, Prens\u00a0EP et al (2017) Menses and pregnancy affect symptoms in hidradenitis suppurativa: a cross-sectional study. J\u00a0Am Acad Dermatol 76:155\u2013156","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"4850_CR23","first-page":"901","volume":"16","author":"AR Vossen","year":"2018","unstructured":"Vossen\u00a0AR, van der Zee\u00a0HH, Terian\u00a0M et al (2018) Laser-Haarentfernung ver\u00e4ndert den Krankheitsverlauf bei leichter Hidradenitis suppurativa. J\u00a0Dtsch Dermatol Ges 16(7):901\u2013903","journal-title":"J Dtsch Dermatol Ges"},{"issue":"5","key":"4850_CR24","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.jaad.2016.06.001","volume":"75","author":"D Wong","year":"2016","unstructured":"Wong\u00a0D, Walsh\u00a0S, Alhusayen\u00a0R (2016) Low-dose systemic corticosteroid treatment for recalcitrant hidradenitis suppurativa. J\u00a0Am Acad Dermatol 75(5):1059\u20131062","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"4850_CR25","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1111\/bjd.15748","volume":"177","author":"CC Zouboulis","year":"2017","unstructured":"Zouboulis\u00a0CC, Tzellos\u00a0T, Kyrgidis\u00a0A et\u00a0al (2017) European hidradenitis suppurativa foundation investigator group. Development and validation of the international hidradenitis suppurativa severity score system (IHS4), a\u00a0novel dynamic scoring system to assess HS severity. Br J Dermatol 177(5):1401\u20131409","journal-title":"Br J Dermatol"},{"issue":"1","key":"4850_CR26","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/jdv.15233","volume":"33","author":"CC Zouboulis","year":"2019","unstructured":"Zouboulis\u00a0CC, Bechara\u00a0FG, Dickinson-Blok\u00a0JL et al (2019) Hidradenitis suppurativa\/acne inversa: a\u00a0practical framework for treatment optimization\u2014systematic review and recommendations from the HS ALLIANCE working group. J\u00a0Eur Acad Dermatol Venereol 33(1):19\u201331","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"12","key":"4850_CR27","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1111\/exd.14214","volume":"29","author":"CC Zouboulis","year":"2020","unstructured":"Zouboulis\u00a0CC, Benhadou\u00a0F, Byrd\u00a0AS et\u00a0al (2020) What causes hidradenitis suppurativa ?\u201415\u00a0years after. Exp Dermatol 29(12):1154\u20131170","journal-title":"Exp Dermatol"},{"issue":"4","key":"4850_CR28","doi-asserted-by":"publisher","first-page":"e251","DOI":"10.1111\/jdv.16976","volume":"35","author":"CC Zouboulis","year":"2021","unstructured":"Zouboulis\u00a0CC, Nogueira da Costa\u00a0A (2021) Drug repurposing through drug-gene interaction profiles for hidradenitis suppurativa\/acne inversa treatment. J\u00a0Eur Acad Dermatol Venereol 35(4):e251\u2013e254","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4850_CR29","unstructured":"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02808975. Zugegriffen: 18.04.2021"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-021-04850-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00105-021-04850-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-021-04850-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,5]],"date-time":"2023-11-05T17:10:28Z","timestamp":1699204228000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00105-021-04850-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,5]]},"references-count":29,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["4850"],"URL":"https:\/\/doi.org\/10.1007\/s00105-021-04850-0","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,5]]},"assertion":[{"value":"26 May 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"H.\u00a0Kurzen, K.\u00a0Fritz und A.\u00a0Altenburg geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patienten zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern eine schriftliche Einwilligung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}